German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "V03AB" (48)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Antidotes (V03AB) 6 products
WHO-DDD
IP
Succicaptal
15 Capsule(s)
k.A.
Capsules: Succimerum 200.54 mg
Curatis AG
A
FB
G
IP
Legalon SIL
4 Durchstechflasche(n)
k.A.
Durchstechflasche mit Trockensubstanz: Silibininum 350 mg
Viatris Pharma GmbH
A
FB
G
IP
CI
Calciumgluconat 2.5%
AApot
k.A.
Hydrogel: Calcii Gluconas 25 mg
Armeeapotheke
D
FB
G
IP
Legalon SIL
4 Durchstechflasche(n)
k.A.
Durchstechflasche mit Trockensubstanz: Silibininum 350 mg
Viatris Pharma GmbH
A
FB
G
IP
CI
Calciumgluconat 2.5%
AApot
Flasche(n)
k.A.
Hydrogel: Calcii Gluconas 25 mg
Armeeapotheke
B
FB
G
IP
Chelintox
5 x 10 ml
k.A.
Injection solution: 2 Active Agents
B. Braun Medical AG
B
FB
G
Thiosulfate (V03AB06) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Pedmarqsi 80 mg/ml
k.A.
Infusion solution: Natrii Thiosulfas Anhydricus 80 mg
Norgine AG
A
FB
G
Obidoxime (V03AB13) 1 products
WHO-DDD
IP
CI
Toxogonin
5 ampoule(s)
k.A.
Injection solution: Obidoximi Chloridum 250 mg/ml
Curatis AG
B
FB
G
Protamine (V03AB14) 1 products
WHO-DDD
DrugBank.ca
IP
Protaminsulfat LEO Pharma
1400 Heparin-Antidot
I.E./ml
5 x 5 ml
k.A.
Injektionslösung und Infusionslösung: Protamini Sulfas 1400 UI/ml
LEO Pharmaceutical
Products Sarath Ltd.
B
FB
G
Naloxone (V03AB15) 2 products
WHO-DDD
DrugBank.ca
IP
Naloxon OrPha
10 ampoule(s)
k.A.
Injection solution: Naloxoni Hydrochloridum Anhydricum
OrPha Swiss GmbH
B
FB
G
IP
CI
Nyxoid 1,8 mg
2
k.A.
Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch
B
FB
G
Methylthioninium Chloride (V03AB17) 2 products
WHO-DDD
IP
Methylthioniniumchlorid
Proveblue 5 mg/ml
5 x 2 ml
k.A.
Injection solution: Methylthioninii Chloridum 5 mg/ml
Laboratorium Dr. G.
Bichsel AG
B
FB
G
IP
Methylthioniniumchlorid
Proveblue 5 mg/ml
5 x 10 ml
k.A.
Injection solution: Methylthioninii Chloridum 5 mg/ml
Laboratorium Dr. G.
Bichsel AG
B
FB
G
Potassium Iodide (V03AB21) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Kaliumiodid 65 SERB
12
k.A.
Tablets: Kalii Iodidum 65 mg
DRAC AG
D
FB
G
IP
CI
Kaliumiodid axapharm 65 mg
10
k.A.
Tablets: Kalii Iodidum 65 mg
axapharm ag
D
FB
G
Acetylcysteine (V03AB23) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Fluimucil 20 %
Durchstechflasche(n) à 25 ml
26.10
k.A.
soluzione per infusione: Acetylcysteinum 5 g
Zambon Svizzera SA
B
FB
G
IP
Solmucol 20% antidoto
20 ml
k.A.
soluzione per infusione: Acetylcysteinum
IBSA Institut
Biochimique SA
B
FB
G
Digitalis Antitoxin (V03AB24) 1 products
WHO-DDD
DrugBank.ca
IP
DigiFab
12 Durchstechflasche(n)
k.A.
Lyophilisate: Digitalis Antitoxinum ovis Fab 36-44 mg
Curatis AG
A
FB
G
Flumazenil (V03AB25) 4 products
WHO-DDD
DrugBank.ca
IP
CI
Anexate
5 1 ampoule(s) à 5 ml
269.60
k.A.
Injection solution: Flumazenilum
Cheplapharm Schweiz
GmbH
B
FB
G
IP
Flumazenil Labatec 0,5
mg/5 ml
5 1 ampoule(s) à 5 ml
k.A.
Injection solution: Flumazenilum
Labatec Pharma SA
B
FB
G
IP
Flumazenil Sintetica 0,5
mg/5 ml
10 1 ampoule(s) à 5 ml
k.A.
Injection solution: Flumazenilum
Sintetica SA
B
FB
G
IP
Flumazenil Labatec 1
mg/10 ml
5 1 ampoule(s) à 10 ml
k.A.
Injection solution: Flumazenilum 1mg / 10ml
Labatec Pharma SA
B
FB
G
Methionine (V03AB26) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Acimethin
50 Tablet(s)
38.80
k.A.
Coated tablets: Methioninum 500 mg
Mepha Pharma AG
B
FB
G
IP
CI
Acimethin
100 Tablet(s)
68.30
k.A.
Coated tablets: Methioninum 500 mg
Mepha Pharma AG
B
FB
G
Hydroxocobalamin (V03AB33) 1 products
WHO-DDD
DrugBank.ca
IP
Cyanokit 5g
Durchstechflasche(n) à 5 g
k.A.
Lyophilisate for infusion solution: Hydroxocobalaminum 5 g
Curatis AG
A
FB
G
Sugammadex (V03AB35) 20 products
WHO-DDD
DrugBank.ca
IP
Bridion 200 mg/2 ml
10 ampoule(s)
k.A.
Injection solution: Sugammadexum 200mg / 2ml
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
Bridion 500 mg/5 ml
10 ampoule(s)
k.A.
Injection solution: Sugammadexum 500mg / 5ml
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
Sugammadex Fresenius i.v. 200
mg/2 ml
10
k.A.
Injection solution: Sugammadexum 200mg / 2ml
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
Sugammadex Fresenius i.v. 500
mg/5 ml
10
k.A.
Injection solution: Sugammadexum 500mg / 5ml
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
Sugammadex Ideogen 200 mg / 2 ml
10 x 2 ml
k.A.
Injection solution: Sugammadexum 200mg / 2ml
Ideogen AG
B
FB
G
IP
Sugammadex Ideogen 500 mg / 5 ml
10 x 5 ml
k.A.
Injection solution: Sugammadexum 500mg / 5ml
Ideogen AG
B
FB
G
IP
Sugammadex Labatec 200
mg/2ml
10
k.A.
Injection solution: Sugammadexum 200mg / 2ml
Labatec Pharma SA
B
FB
G
IP
Sugammadex Labatec 500
mg/5ml
10
k.A.
Injection solution: Sugammadexum 500mg / 5ml
Labatec Pharma SA
B
FB
G
IP
Sugammadex Sandoz 200
mg/2 ml
10
k.A.
Injection solution: Sugammadexum 200mg / 2ml
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Sugammadex Sandoz 500
mg/5 ml
10
k.A.
Injection solution: Sugammadexum 500mg / 5ml
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Sugammadex Sintetica 200
mg/2 ml
10
k.A.
Injection solution: Sugammadexum 200mg / 2ml
Sintetica SA
B
FB
G
IP
Sugammadex Spirig HC 200
mg/2 ml (100 mg/ml)
10 x 2 ml
k.A.
Injection solution: Sugammadexum 200mg / 2ml
Spirig HealthCare AG
B
FB
G
IP
Sugammadex Spirig HC 500
mg/5 ml (100 mg/ml)
10 x 5 ml
k.A.
Injection solution: Sugammadexum 500mg / 5ml
Spirig HealthCare AG
B
FB
G
IP
Sugammadex Viatris 200 mg/ 2 ml
10
k.A.
Injection solution: Sugammadexum 200mg / 2ml
Viatris Pharma GmbH
B
FB
G
IP
Sugammadex Viatris 500 mg/ 5 ml
10
k.A.
Injection solution: Sugammadexum 500mg / 5ml
Viatris Pharma GmbH
B
FB
G
IP
Sugammadex-Mepha 200 mg/2 ml
10
k.A.
Injection solution: Sugammadexum 200mg / 2ml
Mepha Pharma AG
B
FB
G
IP
Sugammadex-Mepha 500 mg/5 ml
10
k.A.
Injection solution: Sugammadexum 500mg / 5ml
Mepha Pharma AG
B
FB
G
IP
Sugammadex Sintetica 500
mg/5 ml
10
k.A.
Injection solution: Sugammadexum 500mg / 5ml
Sintetica SA
B
FB
G
Sugammadex Aguettant 10
mg/ml
10
k.A.
solution injectable en seringue préremplie: Sugammadexum 10 mg/ml
Aguettant Suisse SA
B
FB
G
Sugammadex Aguettant 50
mg/ml
10
k.A.
solution injectable en seringue préremplie: Sugammadexum 50 mg/ml
Aguettant Suisse SA
B
FB
G
Idarucizumab (V03AB37) 1 products
WHO-DDD
DrugBank.ca
IP
PP
Praxbind 2.5 g
2 x 50 ml
k.A.
Injektions- bzw. Infusionslösung: Idarucizumabum 2500mg / 50ml
Boehringer Ingelheim
(Schweiz) GmbH
A
FB
G
Andexanet Alfa (V03AB38) 2 products
WHO-DDD
IP
Ondexxya 200 mg
4
k.A.
Lyophilisate: Andexanet Alfa 200 mg
AstraZeneca AG
A
FB
G
IP
Ondexxya 200 mg
5
k.A.
Lyophilisate: Andexanet Alfa 200 mg
AstraZeneca AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
